Turaco Gold Limited (TCG) ORDINARY FULLY PAID |
Materials |
$478 |
Application for quotation of securities - TCG
|
16 Jul 2025 11:01AM |
$0.465 |
$0.455 |
fallen by
2.15%
|
|
Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA12
|
16 Jul 2025 10:58AM |
n/a |
n/a |
n/a
|
|
Torque Metals Limited (TOR) ORDINARY FULLY PAID |
Materials |
$134 |
Torque Presentation A New Beginning for Paris Gold
|
16 Jul 2025 10:58AM |
$0.170 |
$0.255 |
risen by
50%
|
|
Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$62 |
Prospectus
|
16 Jul 2025 10:57AM |
$0.425 |
$0.280 |
fallen by
34.12%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited is conducting a pro-rata non-renounceable entitlement offer of new shares to existing eligible shareholders.
- The offer seeks to raise capital to support Imugene’s pipeline of immuno-oncology therapies and for general corporate purposes.
- Details about the pricing, eligibility, key dates, and structure of the entitlement offer are provided.
- The company’s clinical programs focus on advancing novel immunotherapies for cancer, leveraging proprietary oncolytic virus and B-cell immunotherapy platforms.
- Funds raised will be used for ongoing clinical trials, research and development, manufacturing, regulatory activities, and working capital.
- The prospectus outlines key risks including clinical trial outcomes, regulatory approval, intellectual property, financial, and market risks.
- Imugene’s recent progress, partnerships, intellectual property status, and management team are described.
- The offer is not underwritten and participation is voluntary for eligible shareholders.
- Legal, taxation, and ASIC compliance information relevant to the offer and shareholders is included.
- Investors are encouraged to read the prospectus in full and seek professional advice before making investment decisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Hazer Group Limited (HZR) ORDINARY FULLY PAID |
Materials |
$101 |
Change of Director's Interest Notice
|
16 Jul 2025 10:56AM |
$0.335 |
$0.385 |
risen by
14.93%
|
|
Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA10
|
16 Jul 2025 10:53AM |
n/a |
n/a |
n/a
|
|
Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA07
|
16 Jul 2025 10:52AM |
n/a |
n/a |
n/a
|
|
Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
Appendix 3Y - Natalie Butler - Late Lodgement
|
16 Jul 2025 10:51AM |
$0.017 |
$0.020 |
risen by
17.65%
|
|
Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA06
|
16 Jul 2025 10:50AM |
n/a |
n/a |
n/a
|
|
Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA04
|
16 Jul 2025 10:49AM |
n/a |
n/a |
n/a
|
|
MPower Group Limited (MPR) ORDINARY FULLY PAID |
Financials |
$3 |
Chairman's address to shareholders
|
16 Jul 2025 10:49AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
Lithium Australia Limited1 (LMA) ORDINARY FULLY PAID |
- |
- |
mFund - Distribution - LMA01
|
16 Jul 2025 10:49AM |
n/a |
n/a |
n/a
|
|
New World Resources Limited (NWC) ORDINARY FULLY PAID |
Materials |
$240 |
TOV: NWC Panel Receives Review Application
|
16 Jul 2025 10:46AM |
$0.066 |
$0.067 |
risen by
2.29%
|
|
NWC - Price-sensitive ASX Announcement
Full Release
Key Points
- NWC Panel received a review application from shareholder TOV on 19 March 2024.
- The application challenges previous decisions relating to New World Resources Limited.
- Concerns involve disclosure adequacy and protection of shareholder interests.
- Panel review process has been initiated in response to TOV’s concerns.
- Relevant parties have been invited to make submissions to the Panel.
- Review will follow established procedural guidelines to ensure fairness.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$6,394 |
SEC Form 4
|
16 Jul 2025 10:44AM |
$34.980 |
$37.610 |
risen by
7.52%
|
|
Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$569 |
PCI Monthly Investment Report- June 2025
|
16 Jul 2025 10:41AM |
$1.185 |
$1.170 |
fallen by
1.27%
|
|
Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$62 |
Imugene Capital Raising Presentation
|
16 Jul 2025 10:40AM |
$0.425 |
$0.280 |
fallen by
34.12%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited is undertaking a capital raising via placement and rights issue to fund its immuno-oncology pipeline.
- The company's pipeline includes multiple clinical and preclinical programs focused on innovative cancer immunotherapies.
- Key assets include HER-Vaxx, PD1-Vaxx, CF33 (VAXINIA & CHECKvacc), and other next-generation oncology candidates.
- Funds raised will support ongoing clinical trials, preclinical studies, and operational expenses.
- Imugene reports strong progress in several clinical trials, including HER-Vaxx (gastric cancer), PD1-Vaxx (non-small cell lung cancer), and the CF33 programs (solid tumours).
- The company has achieved significant regulatory and clinical milestones and anticipates several near-term catalysts.
- Management highlights a robust intellectual property portfolio and multiple opportunities for commercial partnerships.
- Imugene has outlined a clear pathway for value creation through the development and commercialization of its products.
- The presentation details the structure, terms, and expected proceeds from the capital raising activities.
- Imugene remains committed to advancing its mission to develop novel treatments that improve patient outcomes in oncology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$701 |
Final Distribution for 30 June 2025
|
16 Jul 2025 10:39AM |
$3.140 |
$3.150 |
risen by
0.32%
|
|
Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$62 |
Proposed issue of securities - IMU
|
16 Jul 2025 10:39AM |
$0.425 |
$0.280 |
fallen by
34.12%
|
|
Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$62 |
Proposed issue of securities - IMU
|
16 Jul 2025 10:36AM |
$0.425 |
$0.280 |
fallen by
34.12%
|
|
Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$62 |
Imugene Completes $22.5M Placement and c.$15M SPP
|
16 Jul 2025 10:36AM |
$0.425 |
$0.280 |
fallen by
34.12%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene completed a $22.5M placement and approximately $15M via Share Purchase Plan (SPP).
- Proceeds will be used to advance clinical trials for Imugene’s immunotherapy candidates.
- The capital raising received strong support from both institutional and retail investors.
- Funds will support ongoing and future clinical programs, operational expansion, and general corporate activities.
- The announcement reiterates Imugene’s commitment to developing innovative immunotherapies for cancer.
- Details are provided on the allocation of shares, pricing, and the closing of the SPP.
- Recent board and operational updates are included, highlighting strategic priorities.
- The company expresses gratitude to shareholders for their continued support and participation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$20 |
Proposed issue of securities - HIO
|
16 Jul 2025 10:31AM |
$0.021 |
$0.018 |
fallen by
14.29%
|
|
Plato Income Maximiser Limited (PL8) ORDINARY FULLY PAID |
Financials |
$1,063 |
Net Tangible Asset Backing
|
16 Jul 2025 10:26AM |
$1.400 |
$1.420 |
risen by
1.43%
|
|
Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$701 |
Update - Dividend/Distribution - OPH
|
16 Jul 2025 10:22AM |
$3.120 |
$3.150 |
risen by
0.96%
|
|
Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$137 |
Near Surface Laterite Mineralisation Identified at Iguana
|
16 Jul 2025 10:18AM |
$1.100 |
$1.300 |
risen by
18.18%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited identified near surface laterite mineralisation at the Iguana prospect.
- The mineralisation contains elevated nickel, cobalt, and scandium values.
- Aircore drilling confirmed broad zones of mineralisation, open in several directions.
- Further drilling and systematic sampling are planned to better define mineralisation.
- The project is part of the Jaurdi Gold Project in Western Australia.
- Beacon is expanding exploration efforts into battery metals.
- Existing infrastructure and project experience at Jaurdi will be leveraged for new exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$20 |
Update - Proposed issue of securities - HIO
|
16 Jul 2025 10:17AM |
$0.021 |
$0.018 |
fallen by
14.29%
|
|